Chemicals And Allied Products - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Chemicals industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Chemicals And Allied Products - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Chemicals And Allied Products
Corporate Insider Buy Sell Ratio (Insider Count) - Chemicals And Allied Products
Chemicals And Allied Products - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2026-02-25 LYB / LyondellBasell Industries N.V. 4 van der Laan Yvonne A - Award D 76.20 47
2026-02-03 PULM / Pulmatrix, Inc. 4 Higgins Michael J A - Award D 8,800
2025-12-09 RZLT / Rezolute, Inc. 4 Evans Daron P - Purchase D 5.04 10,549
2025-09-17 HLVX / HilleVax, Inc. 4 Sepulveda Jaime U - Other D -59,224
2025-09-17 HLVX / HilleVax, Inc. 4 Cocero Nanette U - Other D -17,199
2025-09-17 HLVX / HilleVax, Inc. 4 Frazier Life Sciences X, L.P. By Frazier Life Sciences X, L.P. U - Other I 1.95 -8,535,337
2025-09-17 HLVX / HilleVax, Inc. 4 Frazier Life Sciences X, L.P. By Patrick J. Heron U - Other I 1.95 -17,199
2025-09-17 HLVX / HilleVax, Inc. 4 Maltbie Shane U - Other D -83,738
2025-09-17 HLVX / HilleVax, Inc. 4 Dubin Gary U - Other D -17,199
2025-09-17 HLVX / HilleVax, Inc. 4 Gerberding Julie L. U - Other D -59,224
2025-09-17 HLVX / HilleVax, Inc. 4 Kohli Aditya U - Other D -698,171
2025-09-17 HLVX / HilleVax, Inc. 4 HILLEMAN JERYL L U - Other D -59,224
2025-09-17 HLVX / HilleVax, Inc. 4 HERSHBERG ROBERT U - Other D -1,101,498
2025-09-17 HLVX / HilleVax, Inc. 4 Chu Shelley U - Other D -17,199
2025-09-17 ESPR / Esperion Therapeutics, Inc. 4 Halladay Benjamin S - Sale D 2.808 -7,046
2025-09-17 ESPR / Esperion Therapeutics, Inc. 4 Looker Benjamin S - Sale D 2.804 -6,267
2025-09-17 ESPR / Esperion Therapeutics, Inc. 4 Koenig Sheldon L. S - Sale D 2.788 -28,427
2025-09-17 KYMR / Kymera Therapeutics, Inc. 4 Jacobs Bruce N. S - Sale D 50.0048 -79,220
2025-09-17 IMMX / Immix Biopharma, Inc. 4 Rachman Ilya M P - Purchase D 2.02 2,500
2025-09-17 KYMR / Kymera Therapeutics, Inc. 4 Jacobs Bruce N. M - Exercise D 2.08 79,220
2025-09-17 NRIX / Nurix Therapeutics, Inc. 4 GREGORY JULIA P M - Exercise D 1.86 10,750
2025-09-16 SRRK / Scholar Rock Holding Corporation 4 Qatanani Mo S - Sale D 33.5200 -3,178
2025-09-16 BYSI / BeyondSpring Inc. 4 Decheng Capital China Life Sciences USD Fund III, L.P. By Decheng Capital China Life Sciences USD Fund III, L.P. S - Sale I 1.88 -840
2025-09-16 CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) 4 Accardi Mario Alberto S - Sale D 21.3333 -7,430
2025-09-16 TNGX / Tango Therapeutics, Inc. 4 Third Rock Ventures IV, L.P. S - Sale D 7.04 -363,541
2025-09-16 CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) 4 Accardi Mario Alberto S - Sale D 22.0213 -742
2025-09-16 APLS / Apellis Pharmaceuticals, Inc. 4 Watson David O. S - Sale D 24.34 -5,000
2025-09-16 AXSM / Axsome Therapeutics, Inc. 4 TABUTEAU HERRIOT S - Sale D 114.19 -19,719
2025-09-16 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 399.281 -1,000
2025-09-16 KYMR / Kymera Therapeutics, Inc. 4 Mainolfi Nello S - Sale D 49 -30,000
2025-09-16 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 400.5937 -3,000
2025-09-16 SRRK / Scholar Rock Holding Corporation 4 Peng Katie S - Sale D 33.1963 -76
2025-09-16 AXSM / Axsome Therapeutics, Inc. 4 Jacobson Mark L. S - Sale D 114.23 -40,000
2025-09-16 AXSM / Axsome Therapeutics, Inc. 4 Jacobson Mark L. S - Sale D 116.19 -5,783
2025-09-16 SRRK / Scholar Rock Holding Corporation 4 Peng Katie S - Sale D 32.4761 -930
2025-09-16 MNKD / MannKind Corporation 4 Tross Stuart A S - Sale D 5.34 -47,000
2025-09-16 IMMX / Immix Biopharma, Inc. 4 Morris Gabriel S P - Purchase D 1.97 2,600
2025-09-16 KYMR / Kymera Therapeutics, Inc. 4 Mainolfi Nello M - Exercise D 2.08 30,000
2025-09-16 AXSM / Axsome Therapeutics, Inc. 4 TABUTEAU HERRIOT M - Exercise D 8.02 19,719
2025-09-16 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A M - Exercise D 120.26 4,000
2025-09-16 AXSM / Axsome Therapeutics, Inc. 4 Jacobson Mark L. M - Exercise D 4.95 25,000
2025-09-16 AXSM / Axsome Therapeutics, Inc. 4 Jacobson Mark L. M - Exercise D 4.85 15,000
2025-09-15 ACAD / ACADIA Pharmaceuticals Inc. 4 Schneyer Mark C. S - Sale D 23.65 -3,498
2025-09-15 KPTI / Karyopharm Therapeutics Inc. 4 Cheng Sohanya Roshan S - Sale D 6.43 -325
2025-09-15 NUVL / Nuvalent, Inc. 4 Porter James Richard S - Sale D 80.12 -2,097
2025-09-15 RNA / Avidity Biosciences, Inc. 4 McCarthy Teresa S - Sale D 41.4095 -15,000
2025-09-15 CSW / CSW Industrials, Inc. 4 Armes Joseph B S - Sale D 250 -1,000
2025-09-15 CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) 4 HUSSAIN IQBAL J S - Sale D 21.8501 -6,000
2025-09-15 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 398.1889 -1,460
2025-09-15 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 397.7086 -2,540
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)